Evidence map›Paper›PMID 35572504›Full record

ArticleFrontiers in immunology2022

The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice.

Cheng Zhang, Huan Cui, Entao Li, Zhendong Guo, Tiecheng Wang, Fang Yan, Lina Liu, Yuanguo Li, Di Chen, Keyin Meng and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SARS-CoV-2 exposure in Norway rats (bioRxiv : the preprint server for biology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Cheng ZhangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Huan CuiChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Entao LiChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Zhendong GuoChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Tiecheng WangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Fang YanChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Lina LiuChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Yuanguo LiChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Di ChenChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Keyin MengChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Nan LiChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Chengfeng QinBeijing Institute of Microbiology and Epidemiology, Beijing, China.
Juxiang LiuCollege of Veterinary Medicine, Hebei Agricultural University, Baoding, China.
Yuwei GaoChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Chunmao ZhangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Chinese Academy of Agricultural Sciences · CNHebei Agricultural University · CNInstitute of Microbiology · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have shown that B.1.351 and other variants have extended the host range of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to mice. Sustained transmission is a prerequisite for viral maintenance in a population. However, no evidence of natural transmission of SARS-CoV-2 in wild mice has been documented to date. Here, we evaluated the replication and contact transmission of the B.1.351 variant in mice and rats. The B.1.351 variant could infect and replicate efficiently in the airways of mice and rats. Furthermore, the B.1.351 variant could not be transmitted in BALB/c or C57BL/6 mice but could be transmitted with moderate efficiency in rats by direct contact. Additionally, the B.1.351 variant did not transmit from inoculated Syrian hamsters to BALB/c mice. Moreover, the mouse-adapted SARS-CoV-2 strain C57MA14 did not transmit in mice. In summary, the risk of B.1.351 variant transmission in mice is extremely low, but the transmission risk in rats should not be neglected. We should pay more attention to the potential natural transmission of SARS-CoV-2 variants in rats and their possible spillback to humans.

Indexed as

COVID-19SARS-CoV-2AnimalsCricetinaeHumansMiceMice, Inbred BALB CMice, Inbred C57BLRatsB.1.351contact transmissionmiceratsSARS-CoV-2

Identifiers

PMID35572504
PMCPMC9095975
OpenAlexW4285742451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.